Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Koya Ono"'
Autor:
Tetsuro Ochi, Tohru Fujiwara, Koya Ono, Chie Suzuki, Maika Nikaido, Daichi Inoue, Hiroki Kato, Koichi Onodera, Satoshi Ichikawa, Noriko Fukuhara, Yasushi Onishi, Hisayuki Yokoyama, Yukio Nakamura, Hideo Harigae
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-16 (2022)
Abstract Acquired sideroblastic anemia, characterized by bone marrow ring sideroblasts (RS), is predominantly associated with myelodysplastic syndrome (MDS). Although somatic mutations in splicing factor 3b subunit 1 (SF3B1), which is involved in the
Externí odkaz:
https://doaj.org/article/40efeea2087145528b821b5cdc5274ec
Autor:
Koya Ono, Tohru Fujiwara, Kei Saito, Hironari Nishizawa, Noriyuki Takahashi, Chie Suzuki, Tetsuro Ochi, Hiroki Kato, Yusho Ishii, Koichi Onodera, Satoshi Ichikawa, Noriko Fukuhara, Yasushi Onishi, Hisayuki Yokoyama, Rie Yamada, Yukio Nakamura, Kazuhiko Igarashi, Hideo Harigae
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-15 (2022)
Abstract X-linked sideroblastic anemia (XLSA), the most common form of congenital sideroblastic anemia, is caused by a germline mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene. In XLSA, defective heme biosynthesis leads to
Externí odkaz:
https://doaj.org/article/e1a90b080410476fbbd19196010c580f
Autor:
Satoshi Ichikawa, Noriko Fukuhara, Tsuyoshi Doman, Daichi Kiba, Yuya Tanaka, Kyoko Inokura, Naoya Morota, Koya Ono, Koichi Onodera, Yasushi Onishi, Hisayuki Yokoyama, Ryo Ichinohasama, Hideo Harigae
Publikováno v:
Journal of Hematopathology. 15:105-109
Autor:
Hirona Ichimura, Satoshi Ichikawa, Koya Ono, Kyoko Inokura, Yosuke Hoshi, Tsuyoshi Shirai, Noriko Fukuhara, Hisayuki Yokoyama, Hiroshi Fujii, Hideo Harigae
Publikováno v:
The Tohoku Journal of Experimental Medicine.
Autor:
Chie Suzuki, Tohru Fujiwara, Hiroki Shima, Koya Ono, Kei Saito, Hiroki Kato, Koichi Onodera, Satoshi Ichikawa, Noriko Fukuhara, Yasushi Onishi, Hisayuki Yokoyama, Yukio Nakamura, Kazuhiko Igarashi, Hideo Harigae
Publikováno v:
Mol Cell Biol
Mitochondria play essential and specific roles during erythroid differentiation. Recently, FAM210B, encoding a mitochondrial inner membrane protein, has been identified as a novel target of GATA-1, as well as an erythropoietin-inducible gene. While F
Autor:
Katsuyuki, Sasaki, Tohru, Fujiwara, Tetsuro, Ochi, Koya, Ono, Hiroki, Kato, Koichi, Onodera, Satoshi, Ichikawa, Noriko, Fukuhara, Yasushi, Onishi, Hisayuki, Yokoyama, Toshio, Miyata, Hideo, Harigae
Publikováno v:
The Tohoku Journal of Experimental Medicine. 257:211-224
Chronic myeloid leukemia (CML) is triggered by t(9;22)(q34;q11.2) translocation, leading to the formation of the BCR-ABL1 fusion gene. Although the development of BCR-ABL1 tyrosine kinase inhibitors (TKIs) has dramatically improved the prognosis of C
Autor:
Koya Ono, Tohru Fujiwara, Hiroki Shima, Hironari Nishizawa, Chie Suzuki, Noriyuki Takahashi, Hiroki Kato, Koichi Onodera, Satoshi Ichikawa, Noriko Fukuhara, Yasushi Onishi, Hisayuki Yokoyama, Yukio Nakamura, Kazuhiko Igarashi, Hideo Harigae
Publikováno v:
Blood. 140:2467-2468
Autor:
Koya Ono, Tohru Fujiwara, Kei Saito, Hironari Nishizawa, Noriyuki Takahashi, Chie Suzuki, Tetsuro Ochi, Hiroki Kato, Yusho Ishii, Koichi Onodera, Satoshi Ichikawa, Noriko Fukuhara, Yasushi Onishi, Hisayuki Yokoyama, Rie Yamada, Yukio Nakamura, Kazuhiko Igarashi, Hideo Harigae
Publikováno v:
Scientific reports. 12(1)
X-linked sideroblastic anemia (XLSA), the most common form of congenital sideroblastic anemia, is caused by a germline mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene. In XLSA, defective heme biosynthesis leads to ring side
Autor:
Yasushi Onishi, Koichi Onodera, Hirofumi Watanabe, Takumi Sawada, Noriko Fukuhara, Hisayuki Yokoyama, Daigo Michimata, Eijiro Furukawa, Koya Ono, Chie Suzuki, Naoya Morota, Hideo Harigae, Satoshi Ichikawa, Kazuki Sakurai
Publikováno v:
Annals of hematology. 101(4)
Autor:
Hideo Harigae, Tohru Tanaka, Shinichi Fujimaki, Hideto Tamura, Kei Saito, Yasushi Onishi, Tohru Fujiwara, Noriko Fukuhara, Hisayuki Yokoyama, Koya Ono, Minami Fujiwara, Katsuyuki Sasaki, Chie Suzuki, Takako Ito, Keita Iwaki
Publikováno v:
The Tohoku Journal of Experimental Medicine. 249:19-28
Multiple myeloma is the cancer of plasma cells. Along with the development of new and effective therapies, improved outcomes in patients with multiple myeloma have increased the interest in minimal residual disease (MRD) monitoring. However, the cons